Literature DB >> 23470238

Challenges in comparing the safety of different vaccination schedules.

Michael L Jackson1.   

Abstract

As vaccine hesitancy has increased in the United States, various authors have begun proposing alternatives to the Advisory Committee on Immunization Practices' recommended childhood immunization schedule. Because parents may believe the safety claims made by such authors, evaluations of the safety of alternative vaccination schedules are needed. However, comparing the safety of different vaccination schedules has numerous methodologic challenges. These challenges include defining vaccination history, defining safety, appropriately modeling interactions between vaccines, and appropriately handling age effects. Failure to properly address these challenges can result in biased results.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23470238     DOI: 10.1016/j.vaccine.2013.02.054

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Authors:  Matthew F Daley; Jason M Glanz; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Marlene M Lugg; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

2.  Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Authors:  Matthew F Daley; Jo Ann Shoup; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil; Jason M Glanz
Journal:  Acad Pediatr       Date:  2018-03-28       Impact factor: 3.107

3.  Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study.

Authors:  Baohua Liu; Ruohui Chen; Miaomiao Zhao; Xin Zhang; Jiahui Wang; Lijun Gao; Jiao Xu; Qunhong Wu; Ning Ning
Journal:  BMC Public Health       Date:  2019-11-27       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.